[go: up one dir, main page]

IT8848614A0 - Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento - Google Patents

Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento

Info

Publication number
IT8848614A0
IT8848614A0 IT8848614A IT4861488A IT8848614A0 IT 8848614 A0 IT8848614 A0 IT 8848614A0 IT 8848614 A IT8848614 A IT 8848614A IT 4861488 A IT4861488 A IT 4861488A IT 8848614 A0 IT8848614 A0 IT 8848614A0
Authority
IT
Italy
Prior art keywords
treatment
carnitine
glaucoma
acetyl
pharmaceutical compositions
Prior art date
Application number
IT8848614A
Other languages
English (en)
Other versions
IT1224795B (it
Inventor
Cavazza Claudio
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of IT8848614A0 publication Critical patent/IT8848614A0/it
Priority to IT8848614A priority Critical patent/IT1224795B/it
Priority to PCT/IT1989/000076 priority patent/WO1990006111A1/en
Priority to AU46584/89A priority patent/AU628116B2/en
Priority to KR1019900701559A priority patent/KR950004885B1/ko
Priority to JP2502051A priority patent/JP2763400B2/ja
Priority to ES199090900320T priority patent/ES2040106T3/es
Priority to EP90900320A priority patent/EP0446268B1/en
Priority to AT90900320T priority patent/ATE88090T1/de
Priority to DE1989606028 priority patent/DE68906028T2/de
Priority to US07/442,702 priority patent/US5145871A/en
Priority to ZA899176A priority patent/ZA899176B/xx
Priority to CA002004239A priority patent/CA2004239C/en
Priority to IE384089A priority patent/IE62568B1/en
Priority to GR890100797A priority patent/GR1000465B/el
Application granted granted Critical
Publication of IT1224795B publication Critical patent/IT1224795B/it
Priority to US07/689,527 priority patent/US5432199A/en
Priority to DK199100950A priority patent/DK175891B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IT8848614A 1988-12-01 1988-12-01 Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento IT1224795B (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT8848614A IT1224795B (it) 1988-12-01 1988-12-01 Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
DE1989606028 DE68906028T2 (de) 1988-12-01 1989-11-27 Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
AU46584/89A AU628116B2 (en) 1988-12-01 1989-11-27 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma
KR1019900701559A KR950004885B1 (ko) 1988-12-01 1989-11-27 아세틸 d-카르니틴을 함유하는 녹내장 치료제
JP2502051A JP2763400B2 (ja) 1988-12-01 1989-11-27 緑内障の治療処置におけるアセチルｄ―カルニチンの用途
ES199090900320T ES2040106T3 (es) 1988-12-01 1989-11-27 Utilizacion de la acetil d-carnitina en el tratamiento terapeutico del glaucoma.
EP90900320A EP0446268B1 (en) 1988-12-01 1989-11-27 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma
AT90900320T ATE88090T1 (de) 1988-12-01 1989-11-27 Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
PCT/IT1989/000076 WO1990006111A1 (en) 1988-12-01 1989-11-27 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma
US07/442,702 US5145871A (en) 1988-12-01 1989-11-28 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment
ZA899176A ZA899176B (en) 1988-12-01 1989-11-30 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
CA002004239A CA2004239C (en) 1988-12-01 1989-11-30 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment
IE384089A IE62568B1 (en) 1988-12-01 1989-11-30 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma
GR890100797A GR1000465B (el) 1988-12-01 1989-12-01 Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιεχουν ακετυλ d-καρνιτινη για την θεραπευτικη αγωγη του γλαυκωματος.
US07/689,527 US5432199A (en) 1988-12-01 1991-04-23 Use of acetyl D-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment
DK199100950A DK175891B1 (da) 1988-12-01 1991-05-21 Anvendelse af acetyl-D-carnitin til fremstilling af et farmaceutisk præparat til terapeutisk behandling af glaukoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848614A IT1224795B (it) 1988-12-01 1988-12-01 Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento

Publications (2)

Publication Number Publication Date
IT8848614A0 true IT8848614A0 (it) 1988-12-01
IT1224795B IT1224795B (it) 1990-10-24

Family

ID=11267644

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8848614A IT1224795B (it) 1988-12-01 1988-12-01 Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento

Country Status (13)

Country Link
US (2) US5145871A (it)
EP (1) EP0446268B1 (it)
JP (1) JP2763400B2 (it)
KR (1) KR950004885B1 (it)
AU (1) AU628116B2 (it)
CA (1) CA2004239C (it)
DK (1) DK175891B1 (it)
ES (1) ES2040106T3 (it)
GR (1) GR1000465B (it)
IE (1) IE62568B1 (it)
IT (1) IT1224795B (it)
WO (1) WO1990006111A1 (it)
ZA (1) ZA899176B (it)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
ATE254923T1 (de) 1998-03-19 2003-12-15 Sigma Tau Ind Farmaceuti Kombinierte zusammensetzung bestehend aus l- karnitin oder l-alkanoylkarnitin, einem glycosaminoglycan und/oder einem seiner bestandteile
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
WO2001058469A1 (en) * 2000-02-08 2001-08-16 Wax Martin B Methods for treating glaucoma
BR0210842A (pt) * 2001-07-06 2004-07-13 Ciba Sc Holding Ag Processo para a preparação de intermediários úteis na sìntese de derivados de estatina, especialmente derivados do ácido 7-amino 3,5-dihidróxi heptanóico, e intermediários dos mesmos
MXPA04003697A (es) * 2001-10-31 2005-04-08 Alcon Inc Proteinas morfogenicas de hueso (bmp), receptores de bmp y proteinas de enlace de bmp y su uso en el diagnostico y tratamiento de glaucoma.
ITRM20020492A1 (it) * 2002-10-01 2004-04-02 Sigma Tau Ind Farmaceuti Uso della propionil l-carnitina per la preparazione di un medicamento per il trattamento del glaucoma.
EP1594439A2 (en) * 2003-02-13 2005-11-16 Albert Einstein College Of Medicine Of Yeshiva University REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US6951658B1 (en) 2003-07-08 2005-10-04 Pearson Research & Development Limited Emu-based compositions for mental well-being and method of use
US7718697B2 (en) * 2003-12-17 2010-05-18 Alcon, Inc. Method for treating glaucoma comprising administering α-lipoic acid
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
EP2363126A1 (en) 2010-03-04 2011-09-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
EP2642991A1 (en) 2010-11-22 2013-10-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutical method for the treatment of the leber optic
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
SG11201403013VA (en) 2011-12-07 2014-07-30 Allergan Inc Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2783695A1 (en) 2013-03-28 2014-10-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin
UA121399C2 (uk) 2014-11-25 2020-05-25 Аллерган, Інк. Стабілізовані композиції для офтальмологічного застосування, які містять омега-3-кислоти
IT201900002913A1 (it) 2019-03-01 2020-09-01 Nicola Pescosolido Composto utile per il trattamento del glaucoma
IT202100020729A1 (it) 2021-08-02 2023-02-02 Univ Degli Studi Di Napoli Federico Ii Preparazione combinata per il trattamento della malattia di Pompe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262864A (en) * 1982-09-17 1989-11-14 Clarence D. Cone Method for producing oncolysis

Also Published As

Publication number Publication date
DK95091D0 (da) 1991-05-21
AU4658489A (en) 1990-06-26
IE893840L (en) 1990-06-01
GR890100797A (en) 1991-03-15
US5145871A (en) 1992-09-08
WO1990006111A1 (en) 1990-06-14
IE62568B1 (en) 1995-02-08
KR950004885B1 (ko) 1995-05-15
JP2763400B2 (ja) 1998-06-11
KR920702216A (ko) 1992-09-03
JPH04502161A (ja) 1992-04-16
ES2040106T3 (es) 1993-10-01
ZA899176B (en) 1990-09-26
GR1000465B (el) 1992-07-30
DK95091A (da) 1991-05-21
AU628116B2 (en) 1992-09-10
CA2004239C (en) 1999-11-09
EP0446268A1 (en) 1991-09-18
IT1224795B (it) 1990-10-24
US5432199A (en) 1995-07-11
DK175891B1 (da) 2005-05-30
CA2004239A1 (en) 1990-06-01
EP0446268B1 (en) 1993-04-14

Similar Documents

Publication Publication Date Title
IT1224795B (it) Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
IT8848558A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
LV10878A (lv) Adas apstradasana ar izveletiem amfifiliem kopolimeriem
IT1179635B (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea
IT1236831B (it) Apparecchio per il trattamento dell'intestino in particolare per enteroclisma
FI952302L (fi) Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
IT8822770A0 (it) Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
FR2636532B1 (fr) Compositions pharmaceutiques
IT1230485B (it) Particelle fini di poliorganosilsesquiossano e procedimento per produrre le stesse
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
IT8867534A0 (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
DK295190A (da) Kosmetik- og hudbehandlingssammensaetninger
FI941345A7 (fi) Retinoidit ja niiden käyttö ihosairauksien ja leukemian hoitoon
IT1229491B (it) Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
IT8721691A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali.
IT8319600A0 (it) Composizioni farmaceutiche e loro uso nel trattamento del glaucoma.
IT8948660A0 (it) Farmaco attivo nel ripristino della plasticita' neuronale
IT1096665B (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza
FI893366A7 (fi) 4-piperidyylimetyyli-2,3-dihydro-1H-isoindoli- ja 2,3,4,5-tetrahydro-1H-bentsatsepiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI901607A7 (fi) Lääkeaine ja sen käyttö parasitoosin käsittelyyn
IT1216556B (it) Derivati peptidici del3_aminodiidrotiofen_2_one, loro preparazione e impiego terapeutico.
IT8619457A1 (it) Derivati insaturi cicloalifatici, loro procedimenti di preparazione e loro impiego in terapia e in cosmetica
FR2598082B1 (fr) Agent prophylactique et therapeutique de traitement de desordres hepatiques
IT8848388A0 (it) Composizione farmaceutica comprendente inosiplex e zidovudina per il trattamento dell'aids e sindromi correlate

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971103